Can less medicine keep leukemia in check?
NCT ID NCT07383298
Summary
This study is looking at whether patients with chronic myeloid leukemia (CML) who are already responding well to their medication can safely take a lower dose. Researchers will observe about 100 patients who switch to taking half their usual amount every other day. The goal is to see if the lower dose is still effective at controlling the leukemia and if it causes fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
Conditions
Explore the condition pages connected to this study.